BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 16324214)

  • 1. Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.
    Golovnina K; Blinov A; Akhmametyeva EM; Omelyanchuk LV; Chang LS
    BMC Evol Biol; 2005 Dec; 5():69. PubMed ID: 16324214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
    Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
    J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merlin differentially associates with the microtubule and actin cytoskeleton.
    Xu HM; Gutmann DH
    J Neurosci Res; 1998 Feb; 51(3):403-15. PubMed ID: 9486775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.
    Huang L; Ichimaru E; Pestonjamasp K; Cui X; Nakamura H; Lo GY; Lin FI; Luna EJ; Furthmayr H
    Biochem Biophys Res Commun; 1998 Jul; 248(3):548-53. PubMed ID: 9703963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition.
    Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The merlin interacting proteins reveal multiple targets for NF2 therapy.
    Scoles DR
    Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein.
    Turunen O; Sainio M; Jääskeläinen J; Carpén O; Vaheri A
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):1-16. PubMed ID: 9748471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.
    James MF; Manchanda N; Gonzalez-Agosti C; Hartwig JH; Ramesh V
    Biochem J; 2001 Jun; 356(Pt 2):377-86. PubMed ID: 11368764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor.
    Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T
    Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene product.
    Omelyanchuk LV; Pertseva JA; Burns SS; Chang LS
    Gene Regul Syst Bio; 2009 Oct; 3():143-57. PubMed ID: 20054405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
    Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.